Page 1 Date 11 November 2020 Re: Management Discussion & Analysis for the 9-months period Ended 30 September 2020 To The President of the Stock Exchange of Thailand (SET) CHAOPRAYAMAHANAKORN PUBLIC

the 3rd quarter ended 30 September 2019 Attn: Director and Manager, The Stock Exchange of Thailand With respect to the financial information for the 3rd quarter ended 30 September 2019, as submitted by

results for the nine-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech

Page 1 No. CMC Sor Lor.013/2019 Date 12 November 2019 Re: Management Discussion & Analysis for the Period Ended 30 September 2019 To The President of the Stock Exchange of Thailand (SET

accommodating increasing transactions in the short-term, the calculation of the capital to accommodate the digital https://www.sec.or.th/EN/Pages/News_Detail.aspx?SECID=8398 SEC Search management of digital

วันที่ 10 พฤษภาคม พ -Translation- 1 Ref. LPN/SorKor/109/2561 10th May, 2018 Re: Report on Financial Analysis in Q1/2018 Dear: President The Stock Exchange of Thailand L.P.N. Development Public Co

1 Ref: AC.006/2019 25 February 2019 Subject: Management discussion and analysis of financial position and operating results To: President and Manager The Stock Exchange of Thailand Overall operating

หนา 1 ของ 5 ORI-FA001/2562 February 25, 2019 Title: The Operating Results of Origin Property Public Company and its Subsidiaries for the year ended December 31, 2018. To The President of The Stock

IP_AC/001/2563 February 24, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited

, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited ( “ the Company” ) would like